Authors:
Derand, R
Bulteau-Pignoux, L
Mettey, Y
Zegarra-Moran, O
Howell, LD
Randak, C
Galietta, LJV
Cohn, JA
Norez, C
Romio, L
Vierfond, JM
Joffre, M
Becq, F
Citation: R. Derand et al., Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation, AM J P-CELL, 281(5), 2001, pp. C1657-C1666
Authors:
Dormer, RL
Derand, R
McNeilly, CM
Mettey, Y
Bulteau-Pignoux, L
Metaye, T
Vierfond, JM
Gray, MA
Galietta, LJV
Morris, MR
Pereira, MMC
Doull, IJM
Becq, F
McPherson, MA
Citation: Rl. Dormer et al., Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells, J CELL SCI, 114(22), 2001, pp. 4073-4081
Authors:
Bulteau, L
Derand, R
Mettey, Y
Metaye, T
Morris, MR
McNeilly, CM
Folli, C
Galietta, LJV
Zegarra-Moran, O
Pereira, MMC
Jougla, C
Dormer, RL
Vierfond, JM
Joffre, M
Becq, F
Citation: L. Bulteau et al., Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells, AM J P-CELL, 279(6), 2000, pp. C1925-C1937
Authors:
Becq, F
Mettey, Y
Gray, MA
Galietta, LJV
Dormer, RL
Merten, M
Metaye, T
Chappe, V
Marvingt-Mounir, C
Zegarra-Moran, O
Tarran, R
Bulteau, L
Derand, R
Pereira, MMC
McPherson, MK
Rogier, C
Joffre, M
Argent, BE
Sarrouilhe, D
Kammouni, W
Figarella, C
Verrier, B
Gola, M
Vierfond, JM
Citation: F. Becq et al., Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel, J BIOL CHEM, 274(39), 1999, pp. 27415-27425